Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Azul chapter 11 filing and $1.6 billion DIP financing
We are advising Azul in connection with its chapter 11 restructuring
Clarivate $500 million incremental term loan facility
We advised the borrower on the transaction
JENA Acquisition Corporation II $230 million IPO
The units were listed on the New York Stock Exchange
General Motors Financial $2.25 billion senior notes offering
The investment-grade notes are due 2027, 2030 and 2035
Amer Sports $1.3 billion secondary offering
We advised Amer Sports on its SEC-registered secondary offering of ordinary shares
Birkenstock $845 million secondary offering and $200 million share repurchase
We advised Birkenstock on the offering and repurchase
Seagate Data Storage Technology $400 million senior notes offering
The notes are due 2030
Bank of America $85 billion euro medium-term note program update
We advised on the update and also advised Bank of America on tax aspects of the program
Bombardier $500 million senior notes offering
The investment-grade senior notes are due 2033
PegBio IPO
We advised PegBio on its IPO and HKEX listing